Correlation Between Rafarma Pharmaceuticals and TSS, Common

Can any of the company-specific risk be diversified away by investing in both Rafarma Pharmaceuticals and TSS, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rafarma Pharmaceuticals and TSS, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rafarma Pharmaceuticals and TSS, Common Stock, you can compare the effects of market volatilities on Rafarma Pharmaceuticals and TSS, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rafarma Pharmaceuticals with a short position of TSS, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rafarma Pharmaceuticals and TSS, Common.

Diversification Opportunities for Rafarma Pharmaceuticals and TSS, Common

0.02

Correlation Coefficient

Rafarma Pharmaceuticals  TSS, Common

Significant diversification

The 3 months correlation between Rafarma and TSS, is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Rafarma Pharmaceuticals and TSS, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TSS, Common Stock and Rafarma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rafarma Pharmaceuticals are associated (or correlated) with TSS, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TSS, Common Stock has no effect on the direction of Rafarma Pharmaceuticals i.e., Rafarma Pharmaceuticals and TSS, Common go up and down completely randomly.

Pair Corralation between Rafarma Pharmaceuticals and TSS, Common

Given the investment horizon of 90 days Rafarma Pharmaceuticals is expected to generate 1.86 times more return on investment than TSS, Common. However, Rafarma Pharmaceuticals is 1.86 times more volatile than TSS, Common Stock. It trades about 0.15 of its potential returns per unit of risk. TSS, Common Stock is currently generating about 0.18 per unit of risk. If you would invest  7.00  in Rafarma Pharmaceuticals on October 20, 2024 and sell it today you would earn a total of  8.00  from holding Rafarma Pharmaceuticals or generate 114.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Rafarma Pharmaceuticals  vs.  TSS, Common Stock

Rafarma Pharmaceuticals

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rafarma Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Rafarma Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

TSS, Common Stock

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in TSS, Common Stock are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal basic indicators, TSS, Common demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Rafarma Pharmaceuticals and TSS, Common

The main advantage of trading using opposite Rafarma Pharmaceuticals and TSS, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rafarma Pharmaceuticals position performs unexpectedly, TSS, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TSS, Common will offset losses from the drop in TSS, Common's long position.

The idea behind Rafarma Pharmaceuticals and TSS, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.